This is particularly relevant because over the past three decades, the adoption of a 
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Accumulating evidence point to significant sleep-immune interactions [12] . reciprocal interactions of sleep and innate immunity).
7
It is interesting to note that inflammation and oxidative stress, which appears to be a 8 common element in the pathophysiology of the aforementioned illnesses [39, 40] , have the 9 capacity to disrupt levels of key players in the regulation of sleep homeostasis namely IL-1β,
10
TNF-α, adenosine, and nitric oxide through activating microglia and astrocytes [40, 41] 
15
It is important to point out that the release of these cytokines from astrocytes that may 16 promote sleep is dependent on 'information' regarding the historical activity of local neurons.
17
Such information is provided by intracellular levels of ATP which is released during 18 neurotransmission and hence acts as a surrogate marker of past neural activity [48, 49] .
19
Increased levels of ATP activate purinergic P2X7 receptors on proximate astrocytes and 20 microglia, thereby inducing the synthesis and release of IL-1β and TNF-α together with ATP.
21
This ATP is almost immediately hydrolysed to adenosine by intracellular adenosine kinase,
22
which acts cooperatively on local neurons to promote sleep pressure as described above [50] . 
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It is also worth noting that there is also considerable data, mainly from animal studies, 
Impaired sleep homeostasis in MS
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The prevalence of disturbed sleep patterns in MS patient populations is approximately 62%, for a wider discussion).
11
Hydrogen has been proposed as a potential adjunctive therapy for neuropsychiatric or CFS, and though molecular hydrogen has been proposed as an adjunctive treatment for 17 bipolar disorder [139] , no study to our knowledge has yet to explore this treatment avenue.
18
The use of molecular hydrogen as a treatment for sleep homeostasis is an intriguing 
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Given these putative mechanisms of action, molecular hydrogen should be investigated as an immune activation, and (neuro) inflammation associated with these disorders in a vicious 12 pathophysiological loop.
13
Practice Points:
The interplay of inflammatory and oxidative stress mechanisms in sleep dysfunctions may: 1.Provide an interface of mechanisms involved in neuro-immune pathways in multiple sclerosis, bipolar disorder and chronic fatigue syndrome; 2.Combine into complex abnormalities which may aggravate the course and overall disability attributed to these disorders; 3.Provide novel treatments strategies to address these diverse sleep abnormalities transdiagnostically.
Research Agenda:
Future directions: 1. Confirm the hypothesis that sleep dysfunction may exacerbate oxidative and nitrosative stress, mitochondrial dysfunction, immune activation, and (neuro) inflammation associated with these disorders in a vicious pathophysiological loop. 2. Further investigation of chronotherapeutic, anti-oxidant and anti-inflammatory treatment strategies, such as melatonin and molecular hydrogen in preclinical and clinical studies of bipolar disorder, multiple sclerosis and chronic fatigue syndrome 3. Specific targeted treatments for sleep abnormalities in these neuropsychiatric conditions within the context of precision medicine are clearly awaited. 18. Nikonova EV, Vijayasarathy C, Zhang L, Cater JR, Galante RJ, Ward SE, et al.
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Differences in activity of cytochrome C oxidase in brain between sleep and wakefulness. 28. Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Nagyova I, Mikula P, et al.
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Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease 
